Sona NanotechSNANF 26 Dividend Yield % is 0.00% as of Jul. 02, 2026. GuruFocus rates SNANF with a GF Score™ of 26/100. The stock has 1 warning sign investors should review. Among 64 Medical Diagnostics & Research companies, Sona Nanotech ranks worse than 1562498.44% on this metric.
As of today (2026-07-02), the Trailing Annual Dividend Yield of Sona Nanotech is 0.00%.
The historical rank and industry rank for Sona Nanotech's Dividend Yield % or its related term are showing as below:
SNANF's Dividend Yield % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 1.895 * Ranked among companies with meaningful Dividend Yield % only.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Sona Nanotech (OTCPK:SNANF) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
The historical data trend for Sona Nanotech's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SNANF vs TMO, DHR, IDXX: Dividend Yield % Comparison
For the Diagnostics & Research subindustry, Sona Nanotech's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sona Nanotech Dividend Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Sona Nanotech's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Sona Nanotech's Dividend Yield % falls into.
Sona Nanotech (SNANF) has a Dividend Yield % of 0.00% as of Jul. 02, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Sona Nanotech and its competitors. According to the industry distribution chart, Sona Nanotech ranks #999999 out of 64 companies in the Medical Diagnostics & Research industry.
Is Sona Nanotech's Dividend Yield % too high?
Sona Nanotech's current Dividend Yield % is 0.00%. Based on the distribution chart, Sona Nanotech ranks #999999 out of 64 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Sona Nanotech has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Sona Nanotech's Dividend Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Sona Nanotech ranks #999999 out of 64 companies for Dividend Yield %. This places Sona Nanotech in the lower half of its industry. The industry median Dividend Yield % is 1.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Medical Diagnostics & Research company?
The median Dividend Yield % among Medical Diagnostics & Research companies is 1.90, based on 64 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Sona Nanotech and its competitors. For the Medical Diagnostics & Research industry, the median Dividend Yield % is 1.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sona Nanotech's current Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sona Nanotech stock overvalued right now?
Sona Nanotech (SNANF) has a current Dividend Yield % of 0.00%. The current Dividend Yield % is 0.00%. Sona Nanotech's overall GF Score™ is 26/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Sona Nanotech (SNANF), the current Dividend Yield % is 0.00% as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sona Nanotech Inc is involved in the nanotechnology life sciences industry. It has developed two proprietary methods for the manufacture of rod-shaped gold nanoparticles and is engaged in the research and development of its proprietary technology for use in biomedical applications and multiplex diagnostic testing platforms. The company is using its gold nano rods manufacturing technology to develop new products and methods for cancer treatment, including a Targeted Hyperthermia Therapy (THT). Additionally, it has filed patent applications in the U.S. regarding a gold nanorod conjugation concept for targeted drug delivery, combination therapies for treating cancer, and for an endoscope with an optical fibre and thermal sensor for photothermal therapy.
26GF Score
Get the complete analysis for SNANF
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SNANF has been successfully added to your 
